Investors

Founded in 1979, Advanced Technology Ventures (ATV) is a leading venture capital firm whose operational experience, technology expertise, global network of industry contacts and collaborative participation has helped to build more than 120 companies from inception to IPO and beyond. With approximately $1.5 billion of committed capital, its portfolio includes investments in both the areas of life sciences and information technology. ATV has offices in Waltham, MA and Palo Alto, CA. 

Chicago Growth Partners is a diversified, growth oriented venture capital firm that brings specialized Marketing, Information Technology, and Operations expertise to deals, provided by team members with a long history of relevant experience. Investing in control and non-control as well as leveraged and non-leveraged investments, CGP is free to pursue attractive companies and industries without constraints related to ownership requirements and the use of financial leverage. CGP’s expertise in diversified sectors provides broad investment flexibility, allowing CGP to shift resources quickly in changing market conditions in order to find the most advantageous risk/reward profile for its investments. That flexibility also extends to creative ways of structuring individual investments. CGP’s goal, always, is to structure deals that put companies in the best position to succeed.

Foundation Medical Partners is a venture capital investment firm sponsored by the Cleveland Clinic Foundation. The firm is focused solely on health care with a special interest in medical devices, biopharmaceutical platforms and products, and other opportunities in health care including diagnostics, health care services, and health care information systems.

MPM Capital is the world's largest dedicated investor in life sciences. With committed capital under active management of more than $2.1 billion, MPM is uniquely structured to invest globally in healthcare innovation. Primarily in biotechnology, but also in medical devices and biopharmaceuticals, MPM has seamlessly integrated private and public equity products to target innovation in healthcare and, thereby, deliver exceptional returns to investors.

Oakwood Medical Investors is a life sciences venture capital fund formed to invest in development stage pharmaceutical, biotechnology and medical device companies. Target portfolio companies for Oakwood have an industry "disruptive" technology, demonstrated proof of concept for its lead product and completed a first round of institutional venture financing. Oakwood prides itself on the scientific advisory network it has developed including nationally recognized medical professionals and scientists from leading academic institutions. Oakwood believes that the combination of its scientific knowledge base, life sciences investment experience and investment capital creates a powerful partner for development stage companies. Over the past 16 years, Oakwood's managers have collaborated on more than 35 pharmaceutical, biotechnology and medical device related investments in companies across the nation. Oakwood generally does not require an active management role when making an investment.

Founded in 2000, De Novo Ventures now has $650 million under management and has made more than 40 investments in medical devices and biotechnology across three funds. De Novo invests in all clinical areas and across all stages of enterprise development and growth, from early stage to late stage. Located in Menlo Park, California, the firm invests nationally with a focus on the Western U.S.

Canaan Partners invests in visionary entrepreneurs and provides them the networks, insights and operational guidance required to build high-performance technology and healthcare companies. Founded in 1987, the firm has raised eight funds and completed more than 78 acquisitions and 53 IPOs. With $3 billion under management and a worldwide footprint, the firm is committed to catalyzing the growth of innovative biopharmaceutical, medical device, diagnostics and healthcare infrastructure companies.

Radius Ventures is focused on leading-edge health and life sciences companies. Investments are sought across a wide spectrum, including biotechnology and pharmaceuticals, medical devices, services, and healthcare/life sciences information technology. Located in New York, NY, Radius currently manages approximately $180 million in committed capital.